Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors
Xin Lei, Daniël C. de Groot, Marij J.P. Welters, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 374-392
Open Access | Times Cited: 16

Showing 16 citing articles:

Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis
YaLan Hu, Kui Wang, Yuhua Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Cancer stem cell-derived exosomes in CD8+ T cell exhaustion
Amir Gholami
International Immunopharmacology (2024) Vol. 137, pp. 112509-112509
Closed Access | Times Cited: 5
Role of CD4+ T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment
Qi An, Li Duan, Yuanyuan Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric Cancer
Taiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue, et al.
Journal of Immunotherapy (2025)
Closed Access
Selinexor’s Immunomodulatory Impact in Advancing Multiple Myeloma Treatment
Kereshmeh Tasbihi, Heiko Bruns
Cells (2025) Vol. 14, Iss. 6, pp. 430-430
Open Access
Exploration of SUSD3 in pan-cancer: studying its role, predictive analysis, and biological significance in various malignant tumors in humans
Fei Zhong, Shining Mao, Shu‐Fen Peng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors
François‐Xavier Mauvais, Yamina Hamel, Aymeric Silvin, et al.
Immunity (2025)
Closed Access
Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Hao Li, Ying Chang, Tiefeng Jin, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy
Ziyi Hu, Qiaodong Zhang, Zehua He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Immunological harmony: the dynamic influence of cellular and humoral immunity on pregnancy success
Manoj K. Pandey
Discover Immunity. (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 2
Hepatocellular carcinoma-specific epigenetic checkpoints bidirectionally regulate the antitumor immunity of CD4 + T cells
Shuai Wang, Lijun Meng, Nan Xu, et al.
Cellular and Molecular Immunology (2024)
Closed Access | Times Cited: 2
Genomic instability as a driver and suppressor of anti-tumor immunity
Marta Requesens, Floris Foijer, Hans W. Nijman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Unlocking Immunity: Innovative prostate cancer vaccine strategies
Qiannan Gu, Anning Qi, Ne Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113137-113137
Closed Access | Times Cited: 1
The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy
Ana Rita Salgado Ribeiro, Theresa Neuper, Jutta Horejs‐Hoeck
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10685-10697
Open Access
The importance of type I interferon in orchestrating the cytotoxic T-cell response to cancer
Julia Busselaar, Merel Sijbranda, Jannie Borst
Immunology Letters (2024) Vol. 270, pp. 106938-106938
Open Access
Page 1

Scroll to top